ArticleMolecular therapy. Oncology2024

Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade.

Mulu Z Tesfay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.